M. Buysschaert, Diabétologie clinique , 4ème édition

M. Word-dg-, Disponible sur: http://www.who.int/mediacentre Disponible sur: http://www.chups.jussieu.fr/polys, Disponible sur FMPMC-PS -Endocrinologie -Niveau DCEM1 -Examen National Classant [Internet]. [cité 2 juin 2016], 2010.

. Mesure-de-l-'hémoglobine-glyquée-ameli-sophia, Disponible sur: https://www.ameli-sophia.fr/diabete/mieux-connaitre-diabete/examens-de-suivirecommandes/mesure-de-lhemoglobine-glyquee .html 17, 2016.

. Disponible-sur, diagnostic-etsurveillance-du-diabete/surveillance-du-diabete/surveillance-du-diabete-les-fondamentaux .html 18. Snapshot [Internet]. [cité 2 juin 2016] Disponible sur: http://www.ceeddiabete .org/fr/recherche/ilots-libres/ 19, Les médicaments du diabète : les antidiabétiques oraux (ADO) [Internet]. Diabète - Association Française des Diabétiques -AFD. [cité 2 juin 2016]. Disponible sur

L. Dufaitre-patouraux, P. Vague, and V. Lassmann-vague, Technologie et fiabilit?? de l???autosurveillance glyc??mique : historique et ??tat actuel, Diabetes & Metabolism, vol.29, issue.2, p.80187
DOI : 10.1016/S1262-3636(03)72768-2

». Amisek, ». Blog-archive, and . Formation, Appareillage de la main [Internet]. [cité 2 juin 2016] Disponible sur: http://www.amisek.be/appareillage-de-la-main/ 27

K. Tonyushkina and J. Nichols, Glucose Meters: A Review of Technical Challenges to Obtaining Accurate ResultsAccuracy, utility and complications of continuous glucose monitoring system (CGMS) in pediatric patients with type 1 diabetes], J Diabetes Sci Technol Online. juill Maia FFR, Araújo LR. J Pediatr (Rio J). août, vol.381, issue.304, pp.293-300, 2005.

. Qu, est-ce que la surveillance de la glycémie en continu? [Internet], 2014.

J. Disponible-sur-pickup, S. Freeman, A. Sutton, . Jm, K. Caldwell et al., Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data, BMJ, vol.343, issue.jul07 1, pp.3805-3839, 2011.
DOI : 10.1136/bmj.d3805

. Disponible-sur, Disponible sur: http://www.dexcom.com/sites/dexcom.com/files/international/user_guides/LBL-011900_Rev03- UG-G4-PLATINUM-OUS-mgdL_FR.pdf 39/files/international/user_guides/G5-Mobile-UG-OUS- mgdl-FR.pdf 40. Cengiz E, Tamborlane WV. A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring, Diabetes Technol Ther. juin, vol.3811, p.142, 2009.

K. Pandit, . Jc, and A. Sutton, Continuous glucose monitoring Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, S263?6. 45. Pickup765?74. 46. Soins ambulatoires [Internet]. CERITD. [cité 2 juin 2016]. Disponible sur, 2008.

. Disponible-sur, Disponible sur: http://www.sfdiabete.org/sites/sfd.prod/files/files/ressources/mmm_2009_pompe_a_insuline.pdf 49. Qu'est-ce qu'une pompe à insuline, pdf 48. untitled -mmm_2009_pompe_a_insuline.pdf [Internet]. [cité 2 juin 2016 Medtronic Diabetes Canada [Internet]. [cité 2 juin 2016]. Disponible sur

J. Lawton, J. Kirkham, D. Rankin, D. White, J. Elliott et al., Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial Sensoraugmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase, 243?51. 51, pp.2403-2408, 2011.

J. Sherr and W. Tamborlane, Past, present, and future of insulin pump therapy: better shot at diabetes control, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, vol.31, issue.4, pp.352-61, 2008.
DOI : 10.1002/msj.20055

L. Heinemann, G. Fleming, J. Petrie, R. Holl, R. Bergenstal et al., Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care):716?22. 54. Les acteurs -La pompe à insuline, parlons-en !, avr, vol.38, issue.4, 2015.

«. Le-site and . La-pompe-À-insuline, parlons-en ! » : pour mieux connaître la thérapie par pompe à insuline, Diabète -Association Française des Diabétiques -AFD. [cité 2 juin 2016]

. Disponible-sur, le-site-la-pompe-insuline-parlons-en-pour- mieux-connaitre-la-therapie-par-pompe-005595 58. Go Ahead, Pick Your Pump [Internet]. Diabetes Self-Management, 2006.

. Disponible-sur, diabetesselfmanagement.com/diabetes-resources/tools-tech/go- ahead-pick-your-pump/ 59

C. Cardona and J. Bayona, Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis, J Diabetes Sci Technol, pp.25-2016

J. Selam, T. Sparre, and L. Pedersen, Evolution of Diabetes Insulin Delivery Devices Disponible sur: https://www.novologpro.com/prescribing/insulin-pens/novopen-echo.html 71, html#HxQHf3GkS7gJbFqQ.99 72. Insulinpens [Internet]. [cité 2 juin 2016]. Disponible sur, 2010.

M. Devices-auckl and N. , 11?8. 74. Reynholds C, Antal Z. Analysis of the NovoPen® Echo for the Delivery of Insulin: A Comparison of Usability, Functionality, and Preference among Pediatric Subjects, Their Parents, and Health Care Professionals, J Diabetes Sci Technol. 1 nov, vol.94, issue.6, pp.1476-1484, 2010.

. Stylo-injecteur-datapen-biocorp and . Stylo-insuline, solution santé connectée pour observance traitement Disponible sur: http://www.biocorp.fr/systemes-dinjection-connectes/ 80. GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus -Full Text View -ClinicalTrials.gov [Internet]. [cité 2 juin 2016]. Disponible sur: https://clinicaltrials.gov/ct2/show, 2016.

M. Newswire, M. Sanofi, and . Afrezza®, the Only Inhaled Insulin, Now Available in the U Disponible sur: http://www.multivu.com/players/English/7412351-sanofi-mannkind-afrezza/ 85. Heinemann L. The Failure of Exubera: Are We Beating a Dead Horse?, 518?29. 86. MedTech Memoirs: Inhalable Insulin Flops...Twice [Internet]. [cité 2 juin 2016], 2008.

W. Disponible-sur-nuffer, J. Trujillo, and S. Ellis, Technosphere Insulin (Afrezza), Annals of Pharmacotherapy, vol.58, issue.1, pp.99-106, 2015.
DOI : 10.1111/j.1475-6773.2005.0l374.x

T. Goldberg, E. Wong, and . Afrezza, Insulin Human) Inhalation Powder. Pharm Ther, 735?41. 91. SANOFI ne commercialisera bientôt plus l'insuline Afrezza de Mannkind [Internet], 2015.

. Boursorama, Disponible sur: http://www.boursorama.com/actualites/sanofi-ne- commercialisera-bientot-plus-l-insuline-afrezza-de-mannkind- ad453719d7f7eb027efa7766c442ccbe 92. Sanofi tried and failed with Afrezza. Why does MannKind still think it can win? | FiercePharma [Internet]. [cité 2 juin 2016]. Disponible sur: http://www.fiercepharma.com/pharma/sanofi-tried-and-failed-afrezza-why-does-mannkind-still- think-it-can-win 93, A1CNOW SELF CHECK -A1C Results from Home -PTS Diagnostics [Internet]. [cité

A. Chang, J. Frank, J. Knaebel, J. Fullam, S. Pardo et al., Disponible sur: http://www.ptsdiagnostics.com/a1cnow-selfcheck.html 94 Evaluation of an, 2016.

A. Kit, 1495?503. 95. instructions-for-patient-use.pdf [Internet] Disponible sur: http://www.go-vgo.com/sites/default/files/upload/instructions-for-patient-use.pdf 96 Dosing Information | V-Go [Internet]. [cité 2 juin 2016] Disponible sur: http://www.go- -146 vgo.com/hcp/dosing-information 97. V-Go: A new answer to insulin pumps for Type 2 [Internet]. [cité 2 juin 2016]. Disponible sur: http://www.healthline.com/diabetesmine/v-go-dissecting-a-new-breed-of-patch-pump-for- type-2s#3 98, Insulin Patch Pumps [Internet]. Diabetes Self-Management. 2014 [cité 2 juin 2016]. Disponible sur, 2010.

C. Guignot and . Le-diabète-«tout-connecté», Hubsante ? Promotion de la santé en Nord Pas de Calais, Disponible sur, pp.15-18, 2014.

|. Apps, Disponible sur: https://mysugr, com [Internet]. [cité 2 juin 2016]

. Diabete-infos, Diabeloop : Un pancréas artificiel pour sauver des vies, pour sauver le bonheur de vivre [Internet]. Diabète Infos, Disponible sur, 2016.

J. Yu, B. Shah, E. Ip, and J. Chan, A Markov Model of the Cost-Effectiveness of Pharmacist Care for Diabetes in Prevention of Cardiovascular Diseases: Evidence from Kaiser Permanente Northern California, Journal of Managed Care Pharmacy, vol.19, issue.2, pp.102-116, 2013.
DOI : 10.18553/jmcp.2013.19.2.102

J. Sease, M. Franklin, and K. Gerrald, Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic, American Journal of Health-System Pharmacy, vol.70, issue.1, pp.43-50, 2013.
DOI : 10.2146/ajhp120221